James Arthur Bristol - Net Worth and Insider Trading
James Arthur Bristol Net Worth
The estimated net worth of James Arthur Bristol is at least $423,300 dollars as of 2024-04-29. James Arthur Bristol is the Director of Erasca Inc and owns about 207,500 shares of Erasca Inc (ERAS) stock worth over $423,300. James Arthur Bristol is also the Director of Deciphera Pharmaceuticals Inc and owns about 0 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $0. Details can be seen in James Arthur Bristol's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James Arthur Bristol has not made any transactions after 2022-12-21 and currently still holds the listed stock(s).
Transaction Summary of James Arthur Bristol
James Arthur Bristol Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Arthur Bristol owns 2 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , and Erasca Inc (ERAS) .
Click here to see the complete history of James Arthur Bristol’s form 4 insider trades.
Insider Ownership Summary of James Arthur Bristol
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2021-04-20 | director |
| ERAS | Erasca Inc | 2022-12-21 | director |
James Arthur Bristol Latest Holdings Summary
James Arthur Bristol currently owns a total of 2 stocks. Among these stocks, James Arthur Bristol owns 207,500 shares of Erasca Inc (ERAS) as of December 21, 2022, with a value of $423,300 and a weighting of 100%. James Arthur Bristol also owns 0 shares of Deciphera Pharmaceuticals Inc (DCPH) as of April 20, 2021, with a value of $0 and a weighting of 0%.
Latest Holdings of James Arthur Bristol
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ERAS | Erasca Inc | 2022-12-21 | 207,500 | 2.04 | 423,300 |
| DCPH | Deciphera Pharmaceuticals Inc | 2021-04-20 | 0 | 25.28 | 0 |
Holding Weightings of James Arthur Bristol
James Arthur Bristol Form 4 Trading Tracker
According to the SEC Form 4 filings, James Arthur Bristol has made a total of 1 transactions in Erasca Inc (ERAS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Erasca Inc is the acquisition of 20,000 shares on December 21, 2022, which cost James Arthur Bristol around $82,800.
According to the SEC Form 4 filings, James Arthur Bristol has made a total of 9 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the sale of 7,000 shares on April 20, 2021, which brought James Arthur Bristol around $322,700.
Insider Trading History of James Arthur Bristol
- 1
James Arthur Bristol Trading Performance
GuruFocus tracks the stock performance after each of James Arthur Bristol's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Arthur Bristol is -25.48%. GuruFocus also compares James Arthur Bristol's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Arthur Bristol within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Arthur Bristol's insider trading performs compared to the benchmark.
Performance of James Arthur Bristol
Average Return
-53.57%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.57 | -25.48 | -31.19 | -53.57 | ||
| Relative Return to S&P 500(%) | -11 | -28.69 | -43.75 | -75.96 |
James Arthur Bristol Ownership Network
Ownership Network List of James Arthur Bristol
Ownership Network Relation of James Arthur Bristol
James Arthur Bristol Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
James Arthur Bristol is the director of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include SVP & Regulatory & Quality Jama Pitman , Chief Commercial Officer Daniel C. Martin , and Chief Financial Officer Thomas Patrick Kelly .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, James Arthur Bristol made no insider transaction in Deciphera Pharmaceuticals Inc (DCPH). Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 26,559 shares made by Daniel C. Martin , a net sale of 14,587 shares made by Matthew L Sherman , and a net sale of 11,601 shares made by Thomas Patrick Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 154,121 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 1,687,666 shares were bought by its insiders, resulting in a net purchase of 1,533,545 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
James Arthur Bristol Mailing Address
Above is the net worth, insider trading, and ownership report for James Arthur Bristol. You might contact James Arthur Bristol via mailing address: C/o Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
